当前位置：首页 > 文献互助 > 互助详情

Targeting 5-Hydroxytryptamine Receptor 1A in the Portal Vein to Decrease Portal Hypertension复制

用户ZSlvCqI39U84 1个月前 63 10 已完结

1. 系统已在2025-08-20 09:29:53对应助文件进行删除

2. 如有需要请重新发布求助信息

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.1053/j.gastro.2024.06.007复制

文献链接: https://linkinghub.elsevier.com/retrieve/pii/S0016508524050625复制

其他信息:

出版社: Elsevier BV
作者: Chang-Peng Zhu; Shu-Qing Liu; Ke-Qi Wang; Hai-Lin Xiong; Peio Aristu-Zabalza; Zoe Boyer-Díaz; Ji-Feng Feng; Shao-Hua Song; Cheng Luo; Wan-Sheng Chen; Xin Zhang; Wei-Hua Dong; Jordi Gracia-Sancho; Wei-Fen Xie

上一篇：Effectiveness of exercise in Systemic Lupus Erythematosus

下一篇：DNA triangular prism nanostructure and CRISPR/Cas12a empowered electrochemical biosensor for dual detection of alpha-fetoprotein and microRNA 122

互助时间线

2025-08-17 18:47:50 [完结求助]

系统完结了求助, 已自动确认了萌萌哒2024应助的文件是正确的, 求助状态变成 已完结

2025-08-13 09:29:53 [上传文件]

萌萌哒2024上传了文件(pdf 4.31 MB), 求助状态变成 待确认

2025-08-12 18:47:50 [发起求助]

最新发布的求助

Development of Dual FLT3 and CHK1 PROTACs for the Treatment of AML 10分钟前
What Is the Rate-Limiting Step of Oxygen Reduction Reaction on Fe–N–C Catalysts? 2小时前
MDM2 Degrader as a Promising Therapeutic Strategy for Cancer Treatment 2小时前
Synthetic methods for high-entropy nanomaterials 5小时前
Understanding the role of short- and long-range intermolecular interactions in novel computational drug discovery 5小时前
Synthesis of Novel SRPK1-Targeting Hybrid Compounds Incorporating Antimetabolites for Cancer Therapy 5小时前
Discovery of a First-in-Class SLIT2 Binder Disrupting the SLIT2/ROBO1 Axis via DNA-Encoded Library (DEL) Screening 5小时前
Topoisomerase II inhibitors in oncology: an updated patent review (2016-present) 5小时前
Toll-like receptor agonists as cancer therapeutics: a patent review (2014–2024) 5小时前
A patent review of MLKL modulators (2023 – present) 5小时前
The effect of high tibial osteotomy on osteoarthritis of the knee. An arthroscopic study of 54 knee joints 6小时前
Effects of a contusion load on spinal cord with different curvatures 7小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com